Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dobutamine in Sepsis with Hypoperfusion
NCT05953142Phase 2Not yet recruiting
- Sponsor
- Federal University of São Paulo
- Start
- Feb 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dobutamine in sepsis, sponsored by Federal University of São Paulo. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
dobutamine
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT05953142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05953142.